Literature DB >> 9692072

Personal experience in managing acute compression fractures, their aftermath, and the bone pain syndrome, in osteoporosis.

H M Frost1.   

Abstract

Recovery from acute symptomatic vertebral compression fractures in osteoporosis patients can be said to occur in three broad stages. For over three decades the author managed them in the following way. In the 3-week-long acute stage after the fracture, the patient usually stayed in bed for 4-8 days until able to turn easily from side to side. Then a back support was provided and the patient was allowed up for frequent but brief intervals. In the following approximately 10-week-long healing stage, the patient lay down for 20 min every 2 h (the Intermittent Horizontal Rest Regimen or IHRR). Patients who developed a subsequent lordotic low back pain stage did the IHRR for a further 10 weeks. In the uncommon bone pain syndrome, doing the IHRR for 10 weeks, or occasionally longer, also relieved pain. When the IHRR failed to provide early pain relief in a compliant patient, other causes of the pain were sought and were usually found.

Entities:  

Mesh:

Year:  1998        PMID: 9692072     DOI: 10.1007/s001980050042

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  4 in total

1.  Pain and fracture-related limitations persist 6 months after a fragility fracture.

Authors:  Joanna E M Sale; Lucy Frankel; Stephen Thielke; Larry Funnell
Journal:  Rheumatol Int       Date:  2017-06-20       Impact factor: 2.631

2.  Rehabilitation in osteoporotic vertebral fractures.

Authors:  Elisa Pratelli; Irene Cinotti; Pietro Pasquetti
Journal:  Clin Cases Miner Bone Metab       Date:  2010-01

3.  Misleading history of pain location in 51 patients with osteoporotic vertebral fractures.

Authors:  Martin Friedrich; Georg Gittler; Elisabeth Pieler-Bruha
Journal:  Eur Spine J       Date:  2006-02-07       Impact factor: 3.134

4.  Long-term experiences of pain after a fragility fracture.

Authors:  A Gheorghita; F Webster; S Thielke; J E M Sale
Journal:  Osteoporos Int       Date:  2018-02-17       Impact factor: 4.507

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.